Delivery Order SPE2DB20D2014-SPE2DB25FC13W
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 72 MCG CAPSULE UU 30S. The contract has a ceiling value of $1,929.45 and a completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication LINZESS 145 MCG CAPSULE UU 30S. The contract has a ceiling value of $2,567.16 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, with a ceiling value of $1,639.94 and a period of performance ending on February 14, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.40 firm fixed-price delivery order is for LINZESS 145 MCG CAPSULE UU 30S, with a performance period ending on May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a ceiling value of $3,622.62 and a period of performance through May 17, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of LINZESS 72 MCG CAPSULE medication, with a ceiling value of $9,742.80 and a period of performance through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a medication, with a ceiling value of $2,915.98. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG CAPSULE 30S. The contract has a firm fixed price of $2,058.77 and a completion date of June 6, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,988.88 and is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract is a firm fixed-price type and runs through February 14, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is valued at $1,496.56 and has an ultimate completion date of June 10, 2025. The award is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...